80 related articles for article (PubMed ID: 22394634)
1. [Pharmacological mechanisms of ethyl acetate extraction of Tongbiheji for active T cell signaling molecules].
Guo LK; Chen GX; Liu LJ; Peng LJ; Tan XJ; Liao QH; Jiang C; Peng MH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):265-7. PubMed ID: 22394634
[TBL] [Abstract][Full Text] [Related]
2. AP-1 is involved in ICOS gene expression downstream of TCR/CD28 and cytokine receptor signaling.
Watanabe M; Nakajima S; Ohnuki K; Ogawa S; Yamashita M; Nakayama T; Murakami Y; Tanabe K; Abe R
Eur J Immunol; 2012 Jul; 42(7):1850-62. PubMed ID: 22585681
[TBL] [Abstract][Full Text] [Related]
3. Repressor of GATA-3 can negatively regulate the expression of T cell cytokines through modulation on inducible costimulator.
Zang YS; Fang Z; Liu YA; Li B; Xiu QY
Chin Med J (Engl); 2012 Jun; 125(12):2188-94. PubMed ID: 22884151
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of Bcl-2 expression in ageing T cells by CD137 and CD28].
Yang L; Guo MQ; Chen LY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1427-30. PubMed ID: 17884794
[TBL] [Abstract][Full Text] [Related]
5. [Effect of overall alkali of Tongbiling on CD69 expression activated mouse T lymphocytes].
Chen JF; Chen GX; Li XJ; Quan SM; Zeng YY; Hu YJ; Huang KE; Liu XL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):93-4. PubMed ID: 15132920
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.
Tezuka K; Tsuji T; Hirano D; Tamatani T; Sakamaki K; Kobayashi Y; Kamada M
Biochem Biophys Res Commun; 2000 Sep; 276(1):335-45. PubMed ID: 11006126
[TBL] [Abstract][Full Text] [Related]
7. A signaling-enhanced chimeric receptor to activate the ICOS pathway in T cells.
Vettermann C; Victor HP; Sun Y; Plewa C; Gupta S
J Immunol Methods; 2015 Sep; 424():14-9. PubMed ID: 25956037
[TBL] [Abstract][Full Text] [Related]
8. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
9. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.
Lu H; Kaplan BL; Ngaotepprutaram T; Kaminski NE
J Leukoc Biol; 2009 Feb; 85(2):322-9. PubMed ID: 18988696
[TBL] [Abstract][Full Text] [Related]
10. AILIM/ICOS: its expression and functional analysis with monoclonal antibodies.
Sakamoto S; Tezuka K; Tsuji T; Hori N; Tamatani T
Hybrid Hybridomics; 2001; 20(5-6):293-303. PubMed ID: 11839247
[TBL] [Abstract][Full Text] [Related]
11. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS.
Linterman MA; Rigby RJ; Wong R; Silva D; Withers D; Anderson G; Verma NK; Brink R; Hutloff A; Goodnow CC; Vinuesa CG
Immunity; 2009 Feb; 30(2):228-41. PubMed ID: 19217324
[TBL] [Abstract][Full Text] [Related]
12. Yin zi huang, an injectable multicomponent chinese herbal medicine, is a potent inhibitor of T-cell activation.
Chen X; Krakauer T; Oppenheim JJ; Howard OM
J Altern Complement Med; 2004 Jun; 10(3):519-26. PubMed ID: 15253857
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory pathways as a basic mechanisms of activating a tolerance signal in T cells.
Magott-Procelewska M
Ann Transplant; 2004; 9(3):13-8. PubMed ID: 15759541
[TBL] [Abstract][Full Text] [Related]
14. CD28 and ICOS: similar or separate costimulators of T cells?
van Berkel ME; Oosterwegel MA
Immunol Lett; 2006 Jun; 105(2):115-22. PubMed ID: 16580736
[TBL] [Abstract][Full Text] [Related]
15. TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.
Pouw N; Treffers-Westerlaken E; Mondino A; Lamers C; Debets R
Mol Immunol; 2010 Apr; 47(7-8):1411-20. PubMed ID: 20303179
[TBL] [Abstract][Full Text] [Related]
16. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors.
Riley JL; Mao M; Kobayashi S; Biery M; Burchard J; Cavet G; Gregson BP; June CH; Linsley PS
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11790-5. PubMed ID: 12195015
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Tongbi Mixture 2 on expressions of CD28 and CD152 and content of tumor necrosis factor-alpha in peripheral blood in rats with collagen-induced arthritis].
Liu H; Liu QP; Chen JF; Huang YM; Xu Q; Li SG
Zhong Xi Yi Jie He Xue Bao; 2008 Jul; 6(7):744-7. PubMed ID: 18601859
[TBL] [Abstract][Full Text] [Related]
18. Effects of double blockade of CD28 and inducible-costimulator signaling on anti-glomerular basement membrane glomerulonephritis.
Okano K; Nitta K; Ogawa S; Horita S; Habiro K; Nihei H; Abe R
J Lab Clin Med; 2004 Oct; 144(4):183-92. PubMed ID: 15514586
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
20. ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2.
Weber JP; Fuhrmann F; Feist RK; Lahmann A; Al Baz MS; Gentz LJ; Vu Van D; Mages HW; Haftmann C; Riedel R; Grün JR; Schuh W; Kroczek RA; Radbruch A; Mashreghi MF; Hutloff A
J Exp Med; 2015 Feb; 212(2):217-33. PubMed ID: 25646266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]